TIBER CREEK GROUP for PHRMA
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Issues relating to Intellectual Property protections for Covid-19 treatments and vaccines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
Copyright/Patent/Trademark CPT
S. 1435 - Affordable Prescriptions for Patients Act of 2021; H.R. 2873 - Affordable Prescriptions for Patients Through Promoting Competition Act of 2021
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
Health Issues HCR
Issues related to drug pricing, reimbursement for prescription drugs, and the pharmaceutical supply chain; Issues related to capping out of pocket costs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
Medicare/Medicaid MMM
Issues related to Medicare Part B pricing reform; Issues related to Medicare Part D pricing reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.